![Angie You](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 31/08/2026
Angie J.
You is Chief Executive Officer & Director at Architect Therapeutics, Inc. since 2023.
Independent Director at Attovia Therapeutics, Inc. and Director at Candid Therapeutics, Inc. since 2024.
Independent Director at Oric Pharmaceuticals, Inc. since 2021.
Director at NKGen Biotech Korea Co., Ltd. starting 2025.
Advisor at Casdin Capital.
Senior Advisor at Frazier Management LLC since 2022.
Formerly Chief Executive Officer & Director at Amunix Pharmaceuticals, Inc. from 2018 to 2022.
Director at Rayzebio, Inc. from 2022 to 2024.
Vice President at Venrock Associates from 2005 to 2007.
Chief Business & Strategy Officer at Sierra Oncology, Inc. from 2014 to 2018.
Chief Business Officer at Aragon Pharmaceuticals, Inc. from 2010 to 2013.
Chief Business Officer at Synosia Therapeutics AG in 2009.
Director-Business Development at Exelixis, Inc. Senior Director-Lifecycle Management at Orexigen Therapeutics, Inc. Chief Operating Officer at Ren Pharmaceuticals, Inc. Management Consultant at McKinsey & Co., Inc. Education includes undergraduate degree from Harvard College in 1995 and doctorate from Harvard University in 2001.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/08/2026 | 52.853 ( 0,12% ) | 1 M $ | 31/08/2026 | |
| 31/03/2026 | 28.000 ( 0,03% ) | 363 720 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 09/11/2021 |
| NKGEN BIOTECH KOREA CO., LTD. | Direttore/Membro del Consiglio | 14/08/2025 |
| ATTOVIA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/07/2024 |
Casdin Capital /Private Equity/
 Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital invests in companies located in the United States. The firm focus on life sciences, healthcare, biotechnology, synthetic biology, and technology sectors. It provides financing for early and growth stage capital requirements. | Consulente / Consigliere | - |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Consulente / Consigliere | 01/02/2022 |
| Società | Posizione | Fine |
|---|---|---|
| RAYZEBIO, INC. | Direttore/Membro del Consiglio | 01/07/2024 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Amministratore Delegato | 01/01/2022 |
| SIERRA ONCOLOGY, INC. | Corporate Officer/Principal | 01/12/2018 |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | 01/01/2013 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 17 |
|---|---|
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals products | Health Technology |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NKMAX Co., Ltd. (South korea)
 NKMAX Co., Ltd. (South korea) BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Casdin Capital /Private Equity/
Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital invests in companies located in the United States. The firm focus on life sciences, healthcare, biotechnology, synthetic biology, and technology sectors. It provides financing for early and growth stage capital requirements. | Finance |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
